nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Intravenous versus oral vitamin D therapy in dialysis patients: What is the question?
|
Andress, Dennis L. |
|
2001 |
|
5S5 |
p. S41-S44 4 p. |
artikel |
2 |
Introduction
|
Llach, Francisco |
|
2001 |
|
5S5 |
p. S1-S2 2 p. |
artikel |
3 |
Paricalcitol dosing according to body weight or severity of hyperparathyroidism: A double-blind, multicenter, randomized study
|
Martin, Kevin J. |
|
2001 |
|
5S5 |
p. S57-S63 7 p. |
artikel |
4 |
Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism
|
Llach, Francisco |
|
2001 |
|
5S5 |
p. S45-S50 6 p. |
artikel |
5 |
Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects
|
Llach, Francisco |
|
2001 |
|
5S5 |
p. S20-S33 14 p. |
artikel |
6 |
Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol
|
Sprague, Stuart M. |
|
2001 |
|
5S5 |
p. S51-S56 6 p. |
artikel |
7 |
Therapeutic uses of vitamin D analogues
|
Brown, Alex J. |
|
2001 |
|
5S5 |
p. S3-S19 17 p. |
artikel |
8 |
Vitamin D analogues for the management of secondary hyperparathyroidism
|
Martin, Kevin J. |
|
2001 |
|
5S5 |
p. S34-S40 7 p. |
artikel |